Content about Per Lofberg

May 16, 2012

CVS Caremark has aggressively set its sights on enhancing medication adherence, and the initiatives are paying off as the company estimates that its PBM clients saved nearly $2.4 billion in 2011 because of improved medication adherence for chronic conditions, according to findings of its annual Insights Report.

WOONSOCKET, R.I. — CVS Caremark has aggressively set its sights on enhancing medication adherence, and the initiatives are paying off as the company estimates that its PBM clients saved nearly $2.4 billion in 2011 because of improved medication adherence for chronic conditions, according to findings of its annual Insights Report.

The report, released on Wednesday, reviews drug trend and highlights key issues in pharmacy care. 

December 20, 2011

At its annual Analyst Day in New York on Tuesday, CVS Caremark executives outlined strong growth for 2012 and unveiled several new offerings and initiatives that are expected to help drive profitable long-term growth as it works to reinvent pharmacy and focus on its “integration sweet spots.”

NEW YORK — At its annual Analyst Day in New York on Tuesday, CVS Caremark executives outlined strong growth for 2012 and unveiled several new offerings and initiatives that are expected to help drive profitable long-term growth as it works to reinvent pharmacy and focus on its “integration sweet spots.”

October 7, 2010

The theme of CVS Caremark’s 2010 analyst meeting held Friday morning here in New York...

October 6, 2010

CVS Caremark has appointed Jonathan Roberts as COO of its pharmacy benefit management business. He...

January 10, 2010

CVS Caremark last month named a new president for its PBM business. The company’s selection...

December 22, 2009

If there was any doubt as to the value CVS Caremark places on personalized medicine,...

NEW YORK If there was any doubt as to the value CVS Caremark places on personalized medicine, that doubt no longer should exist.

Clearly, the company believes that one area its PBM can create real value for payers is within pharmacogenomics or personalized medicine. Not only has CVS Caremark tapped Per Lofberg, co-founder of genetic benefit management company Generation Health, to serve as the PBM president, but it also has upped its stake in Generation Health.